Shanghai Labway Clinical Laboratory Co Ltd
Shanghai Labway Clinical Laboratory Co., Ltd. engages in the sale of in-vitro diagnostic products in China. The company distributes in-vitro diagnostic instruments, reagents, and related accessories and consumables. It also provides third-party medical testing, pathological diagnosis services, precision medicine, CRO, and sample bank laboratory services; scientific research technology and testing… Read more
Shanghai Labway Clinical Laboratory Co Ltd (301060) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.081x
Based on the latest financial reports, Shanghai Labway Clinical Laboratory Co Ltd (301060) has a cash flow conversion efficiency ratio of 0.081x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥135.78 Million) by net assets (CN¥1.67 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shanghai Labway Clinical Laboratory Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Shanghai Labway Clinical Laboratory Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Shanghai Labway Clinical Laboratory Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Labway Clinical Laboratory Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Wuxi Chemical Equipment Co. Ltd. A
SHE:001332
|
0.032x |
|
7C Solarparken AG
PINK:SCPKF
|
0.036x |
|
Odfjell B
OL:ODFB
|
0.313x |
|
Lumibird SA
PA:LBIRD
|
0.038x |
|
Blue Ridge Bankshares Inc
NYSE MKT:BRBS
|
0.020x |
|
Xinjiang Sayram Modern Agriculture Co Ltd
SHG:600540
|
-1.614x |
|
Guangzheng Group Co Ltd
SHE:002524
|
0.188x |
|
IEI Integration Corp
TW:3022
|
0.073x |
Annual Cash Flow Conversion Efficiency for Shanghai Labway Clinical Laboratory Co Ltd (2013–2024)
The table below shows the annual cash flow conversion efficiency of Shanghai Labway Clinical Laboratory Co Ltd from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.82 Billion | CN¥216.31 Million | 0.119x | -56.98% |
| 2023-12-31 | CN¥1.98 Billion | CN¥546.99 Million | 0.276x | +645.91% |
| 2022-12-31 | CN¥2.27 Billion | CN¥84.17 Million | 0.037x | -72.83% |
| 2021-12-31 | CN¥1.64 Billion | CN¥223.51 Million | 0.136x | +1.28% |
| 2020-12-31 | CN¥1.25 Billion | CN¥167.87 Million | 0.135x | +131.24% |
| 2019-12-31 | CN¥1.21 Billion | CN¥70.60 Million | 0.058x | -62.80% |
| 2018-12-31 | CN¥1.18 Billion | CN¥184.79 Million | 0.156x | +280.90% |
| 2017-12-31 | CN¥1.10 Billion | CN¥-95.52 Million | -0.086x | -295.93% |
| 2016-12-31 | CN¥614.70 Million | CN¥27.14 Million | 0.044x | -83.09% |
| 2015-12-31 | CN¥305.25 Million | CN¥79.70 Million | 0.261x | +163.44% |
| 2014-12-31 | CN¥201.13 Million | CN¥-82.77 Million | -0.412x | -3402.03% |
| 2013-12-31 | CN¥130.79 Million | CN¥1.63 Million | 0.012x | -- |